Insulin secretion after tolbutamide and after secretin in patients with pancreatic diseases.
D000293:Adolescent; D000328:Adult; D000368:Aged; D000681:Amylases / Q000032:analysis; D001786:Blood Glucose / Q000032:analysis; D002114:Calcinosis / Q000378:metabolism; D003550:Cystic Fibrosis / Q000378:metabolism; D004386:Duodenum / Q000201:enzymology; D005243:Feces / Q000032:analysis; D005260:Female; D005951:Glucose Tolerance Test; D006801:Humans; D007328:Insulin / Q000097:blood / Q000378:metabolism*; D008049:Lipase / Q000032:analysis; D008055:Lipids / Q000032:analysis; D008297:Male; D008875:Middle Aged; D010179:Pancreas / Q000187:drug effects / Q000378:metabolism; D010182:Pancreatic Diseases / Q000378:metabolism*; D010190:Pancreatic Neoplasms / Q000378:metabolism*; D010195:Pancreatitis / Q000378:metabolism; D012633:Secretin; D014044:Tolbutamide
D001786:Blood Glucose; D007328:Insulin; D008055:Lipids; D012633:Secretin; D014044:Tolbutamide; D008049:Lipase; D000681:Amylases